Summary

Eligibility
for males ages 19 years and up (full criteria)
Location
at UC Davis
Dates
study started
completion around

Description

Summary

This phase I/II trial studies the side effects of enzalutamide and indomethacin and to see how well they work in treating patients with prostate cancer that does not respond to treatment with hormones, has come back, or has spread from where it started to other places in the body. Androgens can cause the growth of prostate cancer cells. Hormone therapy using enzalutamide and indomethacin may fight prostate cancer by lowering the amount of androgen the body makes and/or blocking the use of androgen by the tumor cells.

Official Title

A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)

Details

Keywords

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer, Carcinoma, Prostatic Neoplasms, Indomethacin, Enzalutamide

Eligibility

Location

  • University of California Davis Comprehensive Cancer Center accepting new patients
    Sacramento California 95817 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Mamta Parikh
Links
Learn more or sign up for the study here!
ID
NCT02935205
Phase
Phase 1/2 research study
Study Type
Interventional
Participants
Expecting 38 study participants
Last Updated